P. Maqhuzu

Cost drivers in the pharmacological treatment of interstitial lung disease

R. Holle, M. Kreuter, T. Bahmer, 2021, Respiratory Research.

Determinants of health-related quality of life decline in interstitial lung disease

R. Holle, M. Kreuter, T. Bahmer, 2020, Health and Quality of Life Outcomes.

Costs of Pharmacological and Non-Pharmacological Interventions in Interstitial Lung Disease Management in Germany

R. Holle, M. Kreuter, R. Leidl, 2022, Respiration.

Healthcare resource utilisation and medical costs for children with interstitial lung diseases (chILD) in Europe

N. Kiper, M. Griese, S. Cunningham, 2022, Thorax.

Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry

V. Somogyi, P. Maqhuzu, C. Stolpe, 2024, Respiratory research.

Disease trajectories in interstitial lung diseases – data from the EXCITING-ILD registry

V. Somogyi, P. Maqhuzu, C. Stolpe, 2024, Respiratory research.